Clinical Trial Update: Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating filgrastim with or without plerixafor in patients with refractory multiple myeloma previously treated with lenalidomide. The study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Mozobil (plerixafor)
• Neupogen (Filgrastim)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Refractory Multiple Myeloma | Phase 3 | Status: TERMINATED | Results posted: 2014-08-06